Allstate Corp Acquires Shares of 3,567 Humana Inc. (NYSE:HUM)

Allstate Corp purchased a new position in Humana Inc. (NYSE:HUM - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 3,567 shares of the insurance provider's stock, valued at approximately $905,000.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Pinnacle Wealth Management Advisory Group LLC raised its position in Humana by 3.6% in the fourth quarter. Pinnacle Wealth Management Advisory Group LLC now owns 1,070 shares of the insurance provider's stock worth $272,000 after acquiring an additional 37 shares during the period. Atlas Brown Inc. increased its stake in shares of Humana by 0.6% during the 4th quarter. Atlas Brown Inc. now owns 6,352 shares of the insurance provider's stock worth $1,611,000 after purchasing an additional 38 shares during the last quarter. Mather Group LLC. raised its holdings in shares of Humana by 21.0% in the 4th quarter. Mather Group LLC. now owns 236 shares of the insurance provider's stock worth $60,000 after purchasing an additional 41 shares during the period. Capital Advisors Ltd. LLC lifted its stake in Humana by 26.1% in the fourth quarter. Capital Advisors Ltd. LLC now owns 208 shares of the insurance provider's stock valued at $53,000 after purchasing an additional 43 shares during the last quarter. Finally, Retirement Planning Co of New England Inc. grew its holdings in Humana by 4.7% during the fourth quarter. Retirement Planning Co of New England Inc. now owns 966 shares of the insurance provider's stock valued at $245,000 after purchasing an additional 43 shares during the period. 92.38% of the stock is owned by hedge funds and other institutional investors.

Remove Ads

Analyst Upgrades and Downgrades

Several brokerages have issued reports on HUM. Cantor Fitzgerald restated a "neutral" rating and issued a $290.00 target price on shares of Humana in a research note on Wednesday, February 12th. Barclays boosted their price objective on Humana from $255.00 to $270.00 and gave the company an "equal weight" rating in a research note on Thursday, February 13th. JPMorgan Chase & Co. cut their target price on shares of Humana from $257.00 to $256.00 and set a "neutral" rating for the company in a research report on Tuesday, February 18th. Morgan Stanley lowered their price target on shares of Humana from $301.00 to $285.00 and set an "equal weight" rating on the stock in a research report on Wednesday, February 12th. Finally, Truist Financial raised their price objective on shares of Humana from $260.00 to $290.00 and gave the stock a "hold" rating in a report on Monday, January 6th. Eighteen equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of "Hold" and an average target price of $285.68.

Humana Price Performance

Shares of NYSE HUM traded down $1.13 during trading hours on Thursday, reaching $264.67. 1,808,672 shares of the stock traded hands, compared to its average volume of 1,722,925. The company has a market capitalization of $31.94 billion, a P/E ratio of 26.60, a price-to-earnings-growth ratio of 2.05 and a beta of 0.62. The company's 50-day simple moving average is $268.97 and its two-hundred day simple moving average is $272.62. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.68. Humana Inc. has a 52-week low of $213.31 and a 52-week high of $406.46.

Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, topping the consensus estimate of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. Equities research analysts forecast that Humana Inc. will post 16.47 EPS for the current year.

Humana Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be paid a dividend of $0.885 per share. The ex-dividend date of this dividend is Friday, March 28th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.34%. Humana's dividend payout ratio (DPR) is currently 35.58%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.